Microbiome & Immunology of Barrier Tissues
The vast landscape of microbes and microbial products that bathe our body surfaces and mucosae remains a major frontier at the interface of immunology and microbiology. Microbiome research in the track includes efforts to define how microbial-derived products affect immune and epithelial biology and how immune cells remain poised at barriers to respond to pathogens while avoiding detrimental responses against commensals.
Faculty
Copy Link
Sterling Professor of Immunobiology; Investigator, Howard Hughes Medical Institute
Associate Professor of Laboratory Medicine and Immunobiology
Assistant Professor of Medicine (Infectious Diseases)
C.N.H. Long Professor of Microbial Pathogenesis and Director of Microbial Sciences Institute; Chair, Microbial Pathogenesis
William S. and Lois Stiles Edgerly Professor of Neurology and Professor of Immunobiology
Sterling Professor of Immunobiology and Professor of Dermatology and of Molecular, Cellular, and Developmental Biology and of Epidemiology (Microbial Diseases); Investigator, Howard Hughes Medical Institute, (HHMI)
Associate Professor Tenure; Co-leader Cancer Immunology , Yale Cancer Center
Sterling Professor of Immunobiology; Investigator, Howard Hughes Medical Institute
Bayer Professor of Translational Medicine and Professor of Immunobiology, Pathology and Dermatology; Director, Human and Translational Immunology Program; Vice-Chair, Dept. of Immunobiology for the Section of Human and Translational Immunology